Skip to main content
BJDX logo
BJDX
(NASDAQ)
Bluejay Diagnostics, Inc.
$3.88-- (--)
Loading... - Market loading

Bluejay Diagnostics (BJDX) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Bluejay Diagnostics, Inc.
BJDXNasdaq Stock MarketHealthcareMedical Devices

About Bluejay Diagnostics

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Company Information

CEOIndranil Dey
Founded2015
IPO DateNovember 10, 2021
Employees6
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone844 327 7078
Address
360 Massachusetts Avenue, Suite 203 Acton, Massachusetts 01720 United States

Corporate Identifiers

CIK0001704287
CUSIP095633608
ISINUS0956336087
EIN47-3552922
SIC3841

Leadership Team & Key Executives

Indranil Dey
Principal Financial, Accounting and Executive Officer, President, Chief Executive Officer and Director
Kevin Vance
Chief Commercial Officer
Mark W. Feinberg M.D., Ph.D.
Chief Medical Advisor
Dr. Mark W. Feinberg M.D.
Chief Medical Advisor